• E-mail :[email]
  • Phone : +33 4 93953425
  • Location : Valbonne, France
Last update 2021-07-07 17:06:03.83

Massimo MANTEGAZZA PhD Physiology

Course and current status

Current Position

Inserm Research Director (DR2) and Group Leader at the Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), CNRS UMR7275 and Université Côte d'Azur, 660 Route des Lucioles, 06560 Valbonne-Sophia Antipolis, France

Tel. 04 93953425 Email:


Google Scholar:

Research gate: <a href="">Massimo Mantegazza on ResearchGate</a>


■2014 French habilitation to research direction (HDR), University of Nice-Sophia Antipolis

■1998 Ph.D. in Physiology (highest grade) - University of Milan, Italy.

■1996 Professional habilitation - University of Milan, Italy.

■1992 Master (Laurea) degree in Biology (highest grade) - University of Milan, Italy.

■1987 Scientific High School Diploma - Como, Italy.

Main Scientific Interests

Ion channels and physiopathology of neuronal excitability; Epilepsy; Migraine and other Pain Diseases; Peptidic toxins.

Training and professional experience 

■2016-Present Inserm DR2/Group leader: IPMC, Nice-Sophia Antipolis, France.

■2010-2016 - Inserm CR1/Group leader: IPMC, Nice-Sophia Antipolis, France.

■2008-2009 Inserm CR1/Group leader (Mission: Besta Neurological Institute, Milan, Italy)

■2001-2009 Besta Neurological Institute, Milan, Italy - Group leader. Ion channels and pathophysiology of neuronal excitability.

■1997-2001 Department of Pharmacology, University of Washington, Seattle, WA - Senior Fellow with William Catterall. Structure/function relationships and modulation of sodium channels.

■1994-1997 Besta Neurological Institute, Milan, Italy - Ph.D. Student - With Giuliano Avanzini and Enzo Wanke. Firing patterns of cortical neurons and mechanism of action of antiepileptic drugs.

■1993-1994 Dept. of Experimental Biomedical Sciences, University of Padova, Italy - Fellow with Daniela Pietrobon and Jürgen Hescheler (Institute of Pharmacology - Freie University of Berlin, Germany). Single channel analysis of modulation of calcium channels in pituitary cells.

■1991-1992 Dept. General Physiology and Biochemistry - University of Milan, Italy - Undergraduate Student with Enzo Wanke. Physiology and pharmacology of calcium channels and cholinergic receptors in sensory neurons.

Honors and awards

Human Frontier Science Program Long Term Fellowship, 1998−2000.

Atip/Avenir start-up grant (France), 2008-2012.

Scientific Excellence Award (PES) Inserm (France) 2012

Editorial board: Associate Editor for Frontiers in Molecular Neuroscience; reviewing editor for Frontiers in Pharmacology since 2010 and Frontiers in Neuroscience since 2013.

Guest Editor of Neuroscience Letters.

Member of the International League Against Epilepsy/American Epilepsy Society (ILAE/AES) Translational Task Force Group, 2019-2021.

Subproject coordinator, EFP6 European Integrated Project EPICURE, 2007-2011.

Workpackage coordinator, EFP7 European Project DESIRE 2013-2018.

Scientific Board of NeuroMod, Université Côte d'Azur (UCA) interdisciplinary virtual center on Modeling in Neuroscience and Cognition.

CURE Epilepsy (USA) evaluation panel (2013)

Epilepsy Research UK Doctoral Training Centre Assessment Panel (2021).

Referee for 45 journals: Annals of Neurology, Biochimica et Biophysica Acta (BBA), Brain, Brain Research, Brain Research Bulletin, British Journal Pharmacology, Cerebral Cortex, Clinical Evidence, eBioMedicine, eLife, eNeuro, Epilepsia, Epilepsy Research, Epileptic Disorders, European Journal of Neuroscience, Expert Review of Neurotherapeutics, FEBS Letters, Fundamental & Clinical Pharmacology, Genes Brain and Behavior, Human Molecular Genetics, Human Mutation, Journal of Medical Genetics, Journal of Membrane Biology, Journal of Molecular and Cellular Cardiology, Journal of Neurology, Journal of Neurophysiology, Journal of Neuroscience, Journal of Physiology, Marine Drugs, Molecular and Cellular Neuroscience, Nature Communications, Neurobiology of Disease, Neurogenetics, Neurological Sciences, Neuropharmacology, Neuroscience, Neuroscience Letters, Pflugers Archiv-European Journal of Physiology, PLOS Computational Biology, PLOS ONE, PNAS, Scientific Reports, Toxins.

Reviewer for 20 funding agencies. Belgium: FWO Research Foundation-Flanders; France: Agence de la Biomédecine, Agence Nationale de la Recherche (ANR), Emergence Program-City of Paris, Federation pour la Recherche sur le Cerveau (FRC), Fondation pour la Recherche Medicale (FRM), French Foundation for Epilepsy Research (FFRE), University of Nantes-NExT, University Paris V-Descartes. Germany: Federal Ministry for Education and Research (BMBF); Italy: MIUR; New Zealand: Neurological Foundation; Switzerland: National Science Foundation (SNSF); The Netherlands: ZonMw. UK: Epilepsy Research Foundation, LifeArc, Medical Research Council (MRC), University College London, UK Dravet Syndrome Foundation; USA: CURE Epilepsy.

Invited speaker for 72 seminars.


■2002-present. Eight Ph.D. students: Physiology (University of Milano); Life Sciences (University of Nice – Sophia Antipolis). Eleven undergraduate/master students: Biotechnology and Biology Degrees, University of Milano and Milano-Bicocca University; Life and Health Sciences (University of Nice – Sophia Antipolis). Ten postdocs.

Scientific summary

My main research interests are targeted to the study of ion channels and their influence on the pathophysiology of neuronal functions, and to the development of innovative molecular strategies for the treatment of pathological cellular excitability. We are interested in how ion channels shape neuronal physiological functions, in how their modifications cause pathologies and in how they are modulated or blocked by drugs and toxins. In particular, we are studying the different physiological functions of neuronal voltage gated Na+ channels in different neuronal subtypes and the functional effects of their genetic mutations, using animal models and experimental approaches that reproduce pathophysiological conditions. Furthermore, we are interested in the mechanism of trafficking and folding of ion channels, because we have found epileptogenic mutations that cause trafficking/folding defects and we are studying novel approaches to rescue the mutant channels. We are also developing new methods for modulating neuronal excitability by gene delivery and RNA interference, in order to better understand the mechanisms of generation of neuronal network activity and to find novel approaches for limiting pathological excitability.
Patch-clamp recordings (transfected cell lines, transfected neurons, dissociated neurons and brain slices). Field potential recordings in vivo and in brain slices. Video EEG recordings. Molecular biology (cloning, mutagenesis, qPCR). Confocal and quantitative microscopy. Viral transduction and RNA interference. Cell cultures. Animal models.
Image d’exemple